Company: SRPT
Filing Date: 2025-08-29
Form Type: 8-K
Source: 0001193125-25-192794
Chunk: 1

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-08-29
Form: 8-K
Item: Item 1.01
Chunk 1
---
 6, 2028 and on or before the 21st scheduled trading day immediately preceding the maturity date, the Company may redeem for cash all or part of the New Convertible Notes (subject to certain conditions), at its option, if the last reported sale price of the Common Stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive), including the trading day immediately preceding the date on which the Company provides notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption. If the Company elects to redeem fewer than all of the outstanding New Convertible Notes, at least $150.0 million aggregate principal amount of New Convertible Notes must be outstanding and not subject to redemption as of, and after giving effect to, delivery of the relevant notice of redemption.

Holders of the New Convertible Notes may convert their New Convertible Notes at their option at any time prior to the close of business on the business day immediately preceding March 1, 2030 in multiples of $1,000 principal amount, only under the following circumstances:

  during any calendar quarter commencing after the calendar quarter ending on December 31, 2025 (and only during such calendar quarter), if the last reported sale price of the Common Stock for at...  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  during the five business day period after any five consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per $1,000 principal amou...  

  if the Company calls any or all of the New Convertible Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately prior to the redemption date, bu...  

  upon the occurrence of specified corporate events described in the Indenture.  

On or after March 1, 2030, until the close of business on the second scheduled trading day immediately preceding September 1, 2030, holders may convert their New Convertible Notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.

If the Company experiences a fundamental change or gives a notice of redemption with respect to any or all of the New Convertible Notes, as